Learn
all
about

the lab

Company

New scientific and technological developments in the field of laboratory medicine have turned the clinical laboratory of genetics into a multidimensional unit, targeting to time-effective biomedical screening, accurate diagnosis, as well as study of individual response to a wide range of treatment.

The proper application of the above technological achievements is achieved through the practice of modern diagnostic methods, under conditions of high scientific expertise and know-how.

The model diagnostic center “Access To Genome – ATG” utilizes and integrates the most innovative scientific methods in the field of diagnostic genetics, as well as other specialized medical laboratory fields, and by combinying its highly experienced and well-trained scientific team, guarantees maximum reliability and accuracy in all services provided.

Access To Genome – ATG, in line with modern diagnostic data, has been established with the fruitful coexistence of a team of scientists, who believe in innovative ideas and applications. The company’s network includes laboratories in Thessaloniki, Athens and Belgrade, Serbia, which are fully equipped with state-of-the-art biomedical equipment.

Their services focus on Genetics, Molecular Biology, Biopathology and Cytology analyses, which ensure the diagnosis of hundreds of diseases at prenatal and postnatal stages, the pre-implantation diagnosis of embryos during in vitro fertilization, predisposition to the development of diseases (such as various forms of cancer), investigation of infertility and miscarriages, as well as detection of pathogenic microorganisms and viruses.

High Specialization

Scientific

Support

Maximum Reliability

The prior goal of Access To Genome – ATG is the reliability of diagnostic findings and results, the proper handling of diagnostic information and communication with patients and referral physicians, leading to the provision of high quality services.

ATG laboratories participate in external quality control schemes of renowned bodies (INSTAND, WORLD HEALTH ORGANIZATION- WHO, GENOMICS QUALITY ASSESMENT- GenQA),are certified with a quality management system, according to the standard ISO 9001: 2015 and accredited according to the standards of the National Accreditation System (ESYD) with ELOT EN ISO 15189.